GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma

A mesenchymal transition occurs both during the natural evolution of glioblastoma (GBM) and in response to therapy. Here, we report that the adhesion G-protein-coupled receptor, GPR56/ADGRG1, inhibits GBM mesenchymal differentiation and radioresistance. GPR56 is enriched in proneural and classical G...

Descripción completa

Detalles Bibliográficos
Autores: Moreno Monasterio, Marta, Pedrosa, Leire, Paré Brunet, Laia, Pineda, Estela, Bejarano, Leire, Martínez Soler, Fina, Balasubramaniyan, Veerakumar, Ezhilarasan, Ravesanker, Kallarackal, Naveen, Kim, Sung-Hak, Wang, Jia, Audia, Alessandra, Conroy, Siobhan, Marín Aguilera, Mercedes, Ribalta Farrés, Teresa María, Pujol Farré, Teresa, Herreros, Antonio, Tortosa i Moreno, Avelina, Mira, Helena, Alonso, Marta M., Gómez-Manzano, Candelaria, Graus Ribas, Francesc, Sulman, Erik P., Piao, Xianhua, Nakano, Ichiro, Prat Aparicio, Aleix, Bhat, Krishna P., Iglesia, Núria de la
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/118923
Acceso en línea:https://hdl.handle.net/2445/118923
Access Level:acceso abierto
Palabra clave:Glioma
Tumors
Radioteràpia
Gliomas
Radiotherapy
id ES_c8b291f082b9f26f33fa951f030cb556
oai_identifier_str oai:recercat.cat:2445/118923
network_acronym_str ES
network_name_str España
repository_id_str
spelling GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastomaMoreno Monasterio, MartaPedrosa, LeireParé Brunet, LaiaPineda, EstelaBejarano, LeireMartínez Soler, FinaBalasubramaniyan, VeerakumarEzhilarasan, RavesankerKallarackal, NaveenKim, Sung-HakWang, JiaAudia, AlessandraConroy, SiobhanMarín Aguilera, MercedesRibalta Farrés, Teresa MaríaPujol Farré, TeresaHerreros, AntonioTortosa i Moreno, AvelinaMira, HelenaAlonso, Marta M.Gómez-Manzano, CandelariaGraus Ribas, FrancescSulman, Erik P.Piao, XianhuaNakano, IchiroPrat Aparicio, AleixBhat, Krishna P.Iglesia, Núria de laGliomaTumorsRadioteràpiaGliomasTumorsRadiotherapyA mesenchymal transition occurs both during the natural evolution of glioblastoma (GBM) and in response to therapy. Here, we report that the adhesion G-protein-coupled receptor, GPR56/ADGRG1, inhibits GBM mesenchymal differentiation and radioresistance. GPR56 is enriched in proneural and classical GBMs and is lost during their transition toward a mesenchymal subtype. GPR56 loss of function promotes mesenchymal differentiation and radioresistance of glioma initiating cells both in vitro and in vivo. Accordingly, a low GPR56-associated signature is prognostic of a poor outcome in GBM patients even within non-G-CIMP GBMs. Mechanistically, we reveal GPR56 as an inhibitor of the nuclear factor kappa B (NF-κB) signaling pathway, thereby providing the rationale by which this receptor prevents mesenchymal differentiation and radioresistance. A pan-cancer analysis suggests that GPR56 might be an inhibitor of the mesenchymal transition across multiple tumor types beyond GBM.Elsevier2018201820172018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion15 p.application/pdfhttps://hdl.handle.net/2445/118923Articles publicats en revistes (Infermeria Fonamental i Clínica)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1016/j.celrep.2017.10.083Cell Reports, 2017, vol. 21, num. 8, p. 2183-2197https://doi.org/10.1016/j.celrep.2017.10.083cc-by (c) Moreno, Marta et al., 2017http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:recercat.cat:2445/1189232026-05-29T05:05:01Z
dc.title.none.fl_str_mv GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma
title GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma
spellingShingle GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma
Moreno Monasterio, Marta
Glioma
Tumors
Radioteràpia
Gliomas
Tumors
Radiotherapy
title_short GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma
title_full GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma
title_fullStr GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma
title_full_unstemmed GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma
title_sort GPR56/ADGRG1 inhibits mesenchymal differentiation and radioresistance in glioblastoma
dc.creator.none.fl_str_mv Moreno Monasterio, Marta
Pedrosa, Leire
Paré Brunet, Laia
Pineda, Estela
Bejarano, Leire
Martínez Soler, Fina
Balasubramaniyan, Veerakumar
Ezhilarasan, Ravesanker
Kallarackal, Naveen
Kim, Sung-Hak
Wang, Jia
Audia, Alessandra
Conroy, Siobhan
Marín Aguilera, Mercedes
Ribalta Farrés, Teresa María
Pujol Farré, Teresa
Herreros, Antonio
Tortosa i Moreno, Avelina
Mira, Helena
Alonso, Marta M.
Gómez-Manzano, Candelaria
Graus Ribas, Francesc
Sulman, Erik P.
Piao, Xianhua
Nakano, Ichiro
Prat Aparicio, Aleix
Bhat, Krishna P.
Iglesia, Núria de la
author Moreno Monasterio, Marta
author_facet Moreno Monasterio, Marta
Pedrosa, Leire
Paré Brunet, Laia
Pineda, Estela
Bejarano, Leire
Martínez Soler, Fina
Balasubramaniyan, Veerakumar
Ezhilarasan, Ravesanker
Kallarackal, Naveen
Kim, Sung-Hak
Wang, Jia
Audia, Alessandra
Conroy, Siobhan
Marín Aguilera, Mercedes
Ribalta Farrés, Teresa María
Pujol Farré, Teresa
Herreros, Antonio
Tortosa i Moreno, Avelina
Mira, Helena
Alonso, Marta M.
Gómez-Manzano, Candelaria
Graus Ribas, Francesc
Sulman, Erik P.
Piao, Xianhua
Nakano, Ichiro
Prat Aparicio, Aleix
Bhat, Krishna P.
Iglesia, Núria de la
author_role author
author2 Pedrosa, Leire
Paré Brunet, Laia
Pineda, Estela
Bejarano, Leire
Martínez Soler, Fina
Balasubramaniyan, Veerakumar
Ezhilarasan, Ravesanker
Kallarackal, Naveen
Kim, Sung-Hak
Wang, Jia
Audia, Alessandra
Conroy, Siobhan
Marín Aguilera, Mercedes
Ribalta Farrés, Teresa María
Pujol Farré, Teresa
Herreros, Antonio
Tortosa i Moreno, Avelina
Mira, Helena
Alonso, Marta M.
Gómez-Manzano, Candelaria
Graus Ribas, Francesc
Sulman, Erik P.
Piao, Xianhua
Nakano, Ichiro
Prat Aparicio, Aleix
Bhat, Krishna P.
Iglesia, Núria de la
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Glioma
Tumors
Radioteràpia
Gliomas
Tumors
Radiotherapy
topic Glioma
Tumors
Radioteràpia
Gliomas
Tumors
Radiotherapy
description A mesenchymal transition occurs both during the natural evolution of glioblastoma (GBM) and in response to therapy. Here, we report that the adhesion G-protein-coupled receptor, GPR56/ADGRG1, inhibits GBM mesenchymal differentiation and radioresistance. GPR56 is enriched in proneural and classical GBMs and is lost during their transition toward a mesenchymal subtype. GPR56 loss of function promotes mesenchymal differentiation and radioresistance of glioma initiating cells both in vitro and in vivo. Accordingly, a low GPR56-associated signature is prognostic of a poor outcome in GBM patients even within non-G-CIMP GBMs. Mechanistically, we reveal GPR56 as an inhibitor of the nuclear factor kappa B (NF-κB) signaling pathway, thereby providing the rationale by which this receptor prevents mesenchymal differentiation and radioresistance. A pan-cancer analysis suggests that GPR56 might be an inhibitor of the mesenchymal transition across multiple tumor types beyond GBM.
publishDate 2017
dc.date.none.fl_str_mv 2017
2018
2018
2018
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/118923
url https://hdl.handle.net/2445/118923
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1016/j.celrep.2017.10.083
Cell Reports, 2017, vol. 21, num. 8, p. 2183-2197
https://doi.org/10.1016/j.celrep.2017.10.083
dc.rights.none.fl_str_mv cc-by (c) Moreno, Marta et al., 2017
http://creativecommons.org/licenses/by/3.0/es
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Moreno, Marta et al., 2017
http://creativecommons.org/licenses/by/3.0/es
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 15 p.
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv Articles publicats en revistes (Infermeria Fonamental i Clínica)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419308034031616
score 15.811543